Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14061)
All Articles published online
|
Publishing Process of This Article
|
May 4, 2015 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Critical Care Medicine
ISSN
2220-3141
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mirrakhimov AE, Voore P, Khan M, Ali AM. Tumor lysis syndrome: A clinical review. World J Crit Care Med 2015; 4(2): 130-138 [PMID: 25938028 DOI: 10.5492/wjccm.v4.i2.130] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3141/full/v4/i2/130.htm |
| Number | Citing Articles |
| 1 |
Julie C. Birch, Gaurav Khatri, Lori M. Watumull, Yull E. Arriaga, John R. Leyendecker. Unintended Consequences of Systemic and Ablative Oncologic Therapy in the Abdomen and Pelvis. RadioGraphics 2018; 38(4): 1158 doi: 10.1148/rg.2018170137
|
| 2 |
M. Launay, J. Guitton, R. Balluet, A. Moreau, J.-M. Phelip, Y. Tholance, P. Gonzalo. Clinical considerations for DPD deficiency testing in advanced cancer patients: tumor lysis syndrome should be considered as a major interference. Annals of Oncology 2022; 33(8): 850 doi: 10.1016/j.annonc.2022.04.073
|
| 3 |
Yi-Qi Su, Yi-Yi Yu, Bo Shen, Feng Yang, Yu-Xin Nie. Management of acute kidney injury in gastrointestinal tumor: An overview. World Journal of Clinical Cases 2021; 9(35): 10746-10764 doi: 10.12998/wjcc.v9.i35.10746
Abstract(398) |
Core Tip(401) |
Full Article(HTML)(1678)
|
Full Article (PDF)-2591K(225)
|
Full Article (Word)-160K(141)
|
Audio-720K(1)
|
Peer-Review Report-204K(58)
|
Answering Reviewers-95K(62)
|
Times Cited (0)
|
Total Visits (5206)
|
Open
|
| 4 |
Mahan Shafie, Mahbod Issaiy, Mahdi Barkhori, Samaneh Parsa. Plasma cell leukemia presenting as spontaneous tumor lysis syndrome with hypercalcemia. Clinical Case Reports 2022; 10(7) doi: 10.1002/ccr3.5933
|
| 5 |
Kevin Cao, Jesse C Wu, Michelle Hernandez, Latha Ganti. Steroid-Induced Tumor Lysis Syndrome Accompanied by Diabetic Ketoacidosis and Acute Renal Failure in a Non-Hodgkin Lymphoma Patient . Cureus 2022; doi: 10.7759/cureus.24491
|
| 6 |
O’Dene Lewis, Stephen M. Pastores. Oncologic Critical Care. 2020; : 1119 doi: 10.1007/978-3-319-74588-6_92
|
| 7 |
Aaron King, Thomas Maisey, Erica L. Harris, James A. Poulter, David G. Jayne, M. Ibrahim Khot. The contradictory role of febuxostat in ABCG2 expression and potentiating hypericin-mediated photodynamic therapy in colorectal cancers. Photochemical & Photobiological Sciences 2024; doi: 10.1007/s43630-024-00575-w
|
| 8 |
Julie R. Ingelfinger, Mitchell H. Rosner, Mark A. Perazella. Acute Kidney Injury in Patients with Cancer. New England Journal of Medicine 2017; 376(18): 1770 doi: 10.1056/NEJMra1613984
|
| 9 |
Aleksei Titov, Alexey Petukhov, Alena Staliarova, Dmitriy Motorin, Emil Bulatov, Oleg Shuvalov, Surinder M. Soond, Mauro Piacentini, Gerry Melino, Andrey Zaritskey, Nickolai A. Barlev. The biological basis and clinical symptoms of CAR-T therapy-associated toxicites. Cell Death & Disease 2018; 9(9) doi: 10.1038/s41419-018-0918-x
|
| 10 |
Jorge E. Cortes, Marcos de Lima, Hervé Dombret, Elihu H. Estey, Sergio A. Giralt, Pau Montesinos, Christoph Röllig, Adriano Venditti, Eunice S. Wang. Prevention, recognition, and management of adverse events associated with gemtuzumab ozogamicin use in acute myeloid leukemia. Journal of Hematology & Oncology 2020; 13(1) doi: 10.1186/s13045-020-00975-2
|
| 11 |
Nazli ÖZTÜRK, Fatma ARIKAN. Tümör Lizis Sendromunda Hemşirelik Yaklaşımı. Ordu Üniversitesi Hemşirelik Çalışmaları Dergisi 2021; 4(1): 113 doi: 10.38108/ouhcd.782461
|
| 12 |
C. Baudon, F. P. Duhoux, I. Sinapi, J. L. Canon. Tumor lysis syndrome following trastuzumab and pertuzumab for metastatic breast cancer: a case report. Journal of Medical Case Reports 2016; 10(1) doi: 10.1186/s13256-016-0969-5
|
| 13 |
Elizabeth Mary Durfee. Tumor Lysis Syndrome. Critical Care Nurse 2022; 42(3): 19 doi: 10.4037/ccn2022795
|
| 14 |
Houssein Abdul Sater. A Case Report of Inflammatory Syndrome Presenting as Tumor Lysis Syndrome after Single Dose of Nivolumab. Journal of Cancer Prevention & Current Research 2017; 8(2) doi: 10.15406/jcpcr.2017.08.00271
|
| 15 |
H. Taghvaye Masoumi, M. Hadjibabaie, M. Zarif-Yeganeh, O. Arasteh. Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report. Journal of Clinical Pharmacy and Therapeutics 2017; 42(5): 642 doi: 10.1111/jcpt.12556
|
| 16 |
Cindy Pabon, Ashwini K Esnakula, Karen Daily. Tumour lysis syndrome following eribulin for metastatic uterine leiomyosarcoma. BMJ Case Reports 2018; 11(1): e224576 doi: 10.1136/bcr-2018-224576
|
| 17 |
Annalisa Noce, Giulia Marrone, Manuela Di Lauro, Anna Paola Mitterhofer, Maria Josè Ceravolo, Nicola Di Daniele, Guglielmo Manenti, Antonino De Lorenzo. The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney Damage. Cancers 2023; 15(8): 2254 doi: 10.3390/cancers15082254
|
| 18 |
Ioannis Bellos, Konstantinos Kontzoglou, Amanda Psyrri, Vasilios Pergialiotis. Febuxostat administration for the prevention of tumour lysis syndrome: A meta‐analysis. Journal of Clinical Pharmacy and Therapeutics 2019; doi: 10.1111/jcpt.12839
|
| 19 |
Craig Nolan, Lisa M. DeAngelis. The confused oncologic patient: a rational clinical approach. Current Opinion in Neurology 2016; 29(6): 789 doi: 10.1097/WCO.0000000000000392
|
| 20 |
Allen T. Gordon, Olufunso O. Abosede, Songeziwe Ntsimango, Eric C. Hosten, Nonzuzo Myeza, Armorel van Eyk, Leonie Harmse, Adeniyi S. Ogunlaja. Synthesis and anticancer evaluation of copper(II)- and manganese(II)- theophylline mixed ligand complexes. Polyhedron 2022; 214: 115649 doi: 10.1016/j.poly.2022.115649
|
| 21 |
Mitchell H. Rosner, Giovambattista Capasso, Mark A. Perazella. Acute kidney injury and electrolyte disorders in the critically ill patient with cancer. Current Opinion in Critical Care 2017; 23(6): 475 doi: 10.1097/MCC.0000000000000450
|
| 22 |
Reeti Kumar, Suzanne Reed, Joseph R. Stanek, John D. Mahan. Defining kidney outcomes in children with acute lymphoblastic leukemia in the modern era. Pediatric Nephrology 2022; 37(9): 2119 doi: 10.1007/s00467-021-05402-3
|
| 23 |
Reeti Kumar, John D. Mahan, Joseph R. Stanek, Suzanne Reed. Extent of hypertension and renal injury in children surviving acute lymphoblastic leukemia. Pediatric Blood & Cancer 2022; 69(9) doi: 10.1002/pbc.29628
|
| 24 |
LamisHani Elkhatib, MohamedSalaheldin Bayoumy, AbdulatefMohammed Ahmed, MuhammadMatloob Alam, IbraheemFaisal Abosoudah, HassanAli Altrabolsi. Tumor lysis syndrome in pediatric patients with hematological malignancies. Journal of Applied Hematology 2022; 13(3): 118 doi: 10.4103/joah.joah_243_20
|
| 25 |
Maciej Stawny, Aleksandra Gostyńska, Alina Górecka, Dorota Mańkowska, Izabela Kołodziej, Hanna Jankowiak-Gracz, Magdalena Ogrodowczyk. Stability studies of two compounded solutions potentially used in tumor lysis syndrome. Journal of Oncology Pharmacy Practice 2019; 25(6): 1434 doi: 10.1177/1078155219840421
|
| 26 |
Norbert Lameire, Raymond Vanholder, Wim Van Biesen, Dominique Benoit. Acute kidney injury in critically ill cancer patients: an update. Critical Care 2016; 20(1) doi: 10.1186/s13054-016-1382-6
|
| 27 |
Bruce D. Cheson, Sari Heitner Enschede, Elisa Cerri, Monali Desai, Jalaja Potluri, Nicole Lamanna, Constantine Tam. Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia with Novel Targeted Agents. The Oncologist 2017; 22(11): 1283 doi: 10.1634/theoncologist.2017-0055
|
| 28 |
Alaa M. Ali, Aibek E. Mirrakhimov, Camille N. Abboud, Amanda F. Cashen. Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest. Hematological Oncology 2016; 34(2): 69 doi: 10.1002/hon.2292
|
| 29 |
Songpon Getsuwan, Patcharee Komwilaisak, Napat Laoaroon, Patchareeporn Tanming, Kunanya Suwannaying, Surapon Wiangnon, Arunee Jetsrisuparb. Intestinal obstruction from calcium polystyrene sulfonate in pediatric cancer patients. Pediatric Hematology Oncology Journal 2022; 7(4): 122 doi: 10.1016/j.phoj.2022.07.001
|
| 30 |
Walid Macaron, Zaven Sargsyan, Nicholas J. Short. Hyperleukocytosis and leukostasis in acute and chronic leukemias. Leukemia & Lymphoma 2022; 63(8): 1780 doi: 10.1080/10428194.2022.2056178
|
| 31 |
Partow Kebriaei, Corey Cutler, Marcos de Lima, Sergio Giralt, Stephanie J. Lee, David Marks, Akil Merchant, Wendy Stock, Koen van Besien, Matthias Stelljes. Management of important adverse events associated with inotuzumab ozogamicin: expert panel review. Bone Marrow Transplantation 2018; 53(4): 449 doi: 10.1038/s41409-017-0019-y
|
| 32 |
Ninotchka Brydges, Garry J. Brydges. Oncologic Emergencies. AACN Advanced Critical Care 2021; 32(3): 306 doi: 10.4037/aacnacc2021832
|
| 33 |
Helen H. Chung, Elina Tsyvkin. Tumor Lysis Syndrome. Hospital Medicine Clinics 2016; 5(3): 425 doi: 10.1016/j.ehmc.2016.02.004
|
| 34 |
Florian Scurt, Lothar Schrod. Klinische Notfallmedizin Band 1 Wissen. 2020; : 482 doi: 10.1016/B978-3-437-23248-0.00044-4
|
| 35 |
David F. Kisor. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process. 2020; doi: 10.21019/9781582123127.ch20
|
| 36 |
Shuiying Liu, Jinyuan Zhao, Feng Wang. Acute kidney injury in cancer patients. Clinical and Experimental Nephrology 2022; 26(2): 103 doi: 10.1007/s10157-021-02131-7
|
| 37 |
Kris M. Mahadeo, Francesco Paolo Tambaro, Cristina Gutierrez. Chimeric Antigen Receptor T-Cell Therapies for Cancer. 2020; : 65 doi: 10.1016/B978-0-323-66181-2.00006-8
|
| 38 |
E Araúz-Valdés, L Fernández-Castañeda , E D’Orcy. Tumor de tejidos blandos como presentación atípica de linfoma de Burkitt esporádico. Reporte de caso. Revista Hematología 2024; 27(3) doi: 10.48057/hematologa.v27i3.539
|
| 39 |
Robert Chapman, Sita Shah, Alberto D’Angelo. Acute kidney injury following induction of chemotherapy: Diagnosis and management in critical care. Journal of the Intensive Care Society 2023; 24(1): 112 doi: 10.1177/17511437221106441
|
| 40 |
B. L. Ferreyro, L. Munshi. Annual Update in Intensive Care and Emergency Medicine 2019. Annual Update in Intensive Care and Emergency Medicine 2019; : 31 doi: 10.1007/978-3-030-06067-1_3
|
| 41 |
Aurélien Mary, Amélie Boursier, Michel Brazier, Patrice Fardellone. Pharmacie Clinique et Thérapeutique. 2018; : 303 doi: 10.1016/B978-2-294-75077-9.00020-7
|
| 42 |
Julie Beaume, Antoine Braconnier, Thibault Dolley-Hitze, Jean-Philippe Bertocchio. Bicarbonate : de la physiologie aux applications thérapeutiques pour tout clinicien. Néphrologie & Thérapeutique 2018; 14(1): 13 doi: 10.1016/j.nephro.2017.02.014
|
| 43 |
Matthew Abramson, Ali Mehdi. Hematological Malignancies and the Kidney. Advances in Chronic Kidney Disease 2022; 29(2): 127 doi: 10.1053/j.ackd.2022.02.003
|
| 44 |
Marta Romo-González, Sara Moreno-Paz, Violeta García-Hernández, Fermín Sánchez-Guijo, Ángel Hernández-Hernández. Inhibition of Xanthine Oxidoreductase Enhances the Potential of Tyrosine Kinase Inhibitors against Chronic Myeloid Leukemia. Antioxidants 2020; 9(1): 74 doi: 10.3390/antiox9010074
|
| 45 |
Nadia Taha, Gopika Bhaskar. Spontaneous Tumour Lysis Syndrome in Mantle Cell Lymphoma: A Case Study. Cureus 2022; doi: 10.7759/cureus.29851
|
| 46 |
O’Dene Lewis, Stephen M. Pastores. Oncologic Critical Care. 2019; : 1 doi: 10.1007/978-3-319-74698-2_92-1
|
| 47 |
Ameneh Jafari, Mostafa Rezaei-Tavirani, Maryam Salimi, Reza Tavakkol, Zahra Jafari. Oncological Emergencies from Pathophysiology and Diagnosis to Treatment: A Narrative Review. Social Work in Public Health 2020; 35(8): 689 doi: 10.1080/19371918.2020.1824844
|
| 48 |
Daniel Pindak, Katarina Rejlekova, Miroslav Tomas, Ramadan Aziri, Eva Rovenska, Judita Puskacova, Michal Mego. Intraoperative tumor lysis syndrome in a giant teratoma: a case report. BMC Surgery 2019; 19(1) doi: 10.1186/s12893-019-0526-4
|
| 49 |
Chinatsu Kurasaka, Nana Nishizawa, Yoko Ogino, Akira Sato. Anticancer sensitivity and biological aspect of 5-fluorouracil-resistant human colorectal cancer HCT116 cells in three-dimensional culture under high- and low-glucose conditions. Nucleosides, Nucleotides & Nucleic Acids 2024; : 1 doi: 10.1080/15257770.2024.2332414
|
| 50 |
Gianfilippo Nifosì. Hematologic Emergencies. Open Journal of Internal Medicine 2016; 6(03): 83 doi: 10.4236/ojim.2016.63014
|
| 51 |
V.I. Potievskaya, A.A. Akhobekov. Classification of cardio-oncology syndromes in assessing the interaction of cardiovascular diseases and cancer. Kardiologiya i serdechno-sosudistaya khirurgiya 2023; 16(5): 529 doi: 10.17116/kardio202316051529
|
| 52 |
Philip R Cohen, Victor G Prieto, Razelle Kurzrock. Tumor Lysis Syndrome: Introduction of a Cutaneous Variant and a New Classification System. Cureus 2021; doi: 10.7759/cureus.13816
|
| 53 |
Athanasios Tragiannidis, Maria Papageorgiou, Maria Stamou, Emmanuel Hatzipantelis, Theodotis Papageorgiou, Andreas Giannopoulos, Lamprini Damianidou, Anna Pappa, Stiliani Pappa, Maria Hatzistilianou. Tumor lysis-like syndrome in a child during treatment for visceral leishmaniasis. International Journal of Immunopathology and Pharmacology 2016; 29(3): 458 doi: 10.1177/0394632016640788
|
| 54 |
Ricardo Ambrósio Rodrigues, Telma Alves, Christine Joannie Canizes Paiva, João Rocha Gonçalves. Acute flaccid paralysis due to multifactorial hyperkalaemia. BMJ Case Reports 2023; 16(6): e255608 doi: 10.1136/bcr-2023-255608
|
| 55 |
Emily L. Joyce, Sandra L. Kane-Gill, Dana Y. Fuhrman, John A. Kellum. Drug-associated acute kidney injury: who’s at risk?. Pediatric Nephrology 2017; 32(1): 59 doi: 10.1007/s00467-016-3446-x
|
| 56 |
Wiebke Wesemüller, Christian Taverna. Spontaneous Tumor Lysis Syndrome. Case Reports in Oncology 2020; 13(3): 1116 doi: 10.1159/000509643
|
| 57 |
Michail Papapanou, Anastasios E. Athanasopoulos, Eleni Georgiadi, Stefanos A. Maragkos, Michalis Liontos, Dimitrios C. Ziogas, Dimitrios Damaskos, Dimitrios Schizas. Spontaneous tumor lysis syndrome in patients with solid tumors: a scoping review of the literature. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02108-4
|
| 58 |
Shaunak Navalkissoor, Christos Toumpanakis, Martyn Caplin, Gopinath Gnanasegaran. Treatment of neuroendocrine tumours with 177Lu‐peptide receptor radionuclide therapy: Challenging clinical scenarios and their management. Journal of Neuroendocrinology 2022; 34(4) doi: 10.1111/jne.13088
|
| 59 |
Benjamin Rahmani, Shrey Patel, Omar Seyam, Jason Gandhi, Inefta Reid, Noel Smith, Sardar Ali Khan. Current understanding of tumor lysis syndrome. Hematological Oncology 2019; 37(5): 537 doi: 10.1002/hon.2668
|
| 60 |
Elżbieta Iskierka-Jażdżewska, Tadeusz Robak. Minimizing and managing treatment-associated complications in patients with chronic lymphocytic leukemia. Expert Review of Hematology 2020; 13(1): 39 doi: 10.1080/17474086.2020.1696185
|
| 61 |
Ales Groselj, Masa Bosnjak, Primoz Strojan, Mojca Krzan, Maja Cemazar, Gregor Sersa. Efficiency of electrochemotherapy with reduced bleomycin dose in the treatment of nonmelanoma head and neck skin cancer: Preliminary results. Head & Neck 2018; 40(1): 120 doi: 10.1002/hed.24991
|
| 62 |
Kai Huang, Winfried Brenner, Vikas Prasad. Tumor Lysis Syndrome: A Rare but Serious Complication of Radioligand Therapies. Journal of Nuclear Medicine 2019; 60(6): 752 doi: 10.2967/jnumed.118.217380
|
| 63 |
Vivek Alaigh, Debapriya Datta. Spontaneous Tumor Lysis Syndrome due to Uterine Leiomyosarcoma with Lung Metastases. Case Reports in Critical Care 2017; 2017: 1 doi: 10.1155/2017/4141287
|
| 64 |
Marta Skoczyńska, Małgorzata Chowaniec, Anna Szymczak, Anna Langner-Hetmańczuk, Beata Maciążek-Chyra, Piotr Wiland. Pathophysiology of hyperuricemia and its clinical significance – a narrative review. Rheumatology 2020; 58(5): 312 doi: 10.5114/reum.2020.100140
|
| 65 |
John R. Carr, W. Anthony Hawkins, Andrea Sikora Newsome, Susan E. Smith, Clemmons Amber B, Christopher M. Bland, Trisha N. Branan. Fluid Stewardship of Maintenance Intravenous Fluids. Journal of Pharmacy Practice 2022; 35(5): 769 doi: 10.1177/08971900211008261
|
| 66 |
Phyo Thazin Myint, Hifza Waheed Butt, Taha Alrifai, Carlos Marin. Spontaneous Tumor Lysis Syndrome Secondary to Small-Cell Neuroendocrine Carcinoma of Unknown Origin: A Rare Case Report and Literature Review. Case Reports in Oncological Medicine 2019; 2019: 1 doi: 10.1155/2019/6375693
|
| 67 |
Pamela Carvalho Muniz, Mayndra Mychelle Landgraf, Fernando Silva Picon, Hakaru Tadokoro, Ramon Andrade De Mello, Michelle Samora de Almeida. International Manual of Oncology Practice. 2019; : 945 doi: 10.1007/978-3-030-16245-0_42
|
| 68 |
Shahrier Hossain, Martha Naber, Matthew J Yacobucci. A retrospective observational study of a low fixed-dose rasburicase protocol for the treatment of tumor lysis syndrome in adults. Journal of Oncology Pharmacy Practice 2022; 28(6): 1326 doi: 10.1177/10781552211021147
|
| 69 |
Ivanka Percic. Tumor lysis syndrome. Medicinski pregled 2022; 75(Suppl. 1): 157 doi: 10.2298/MPNS22S1157P
|
| 70 |
Praveen Dhyani, Cristina Quispe, Eshita Sharma, Amit Bahukhandi, Priyanka Sati, Dharam Chand Attri, Agnieszka Szopa, Javad Sharifi-Rad, Anca Oana Docea, Ileana Mardare, Daniela Calina, William C. Cho. Anticancer potential of alkaloids: a key emphasis to colchicine, vinblastine, vincristine, vindesine, vinorelbine and vincamine. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02624-9
|
| 71 |
Sharleen Yuan, Samantha J. Yarmis, Kami M. Hu. Oncologic Emergency Medicine. 2021; : 481 doi: 10.1007/978-3-030-67123-5_36
|
| 72 |
Janja Tarčuković, Lara Valenčić, Željka Polonijo, Ana Fućak, Boban Dangubić, Igor Grubješić. Acute Liver Failure as the Leading Manifestation of Spontaneous Tumour Lysis Syndrome in a Patient with NonHodgkin Lymphoma: Do Current Diagnostic Criteria of Tumour Lysis Syndrome Need Re-Evaluation?. Case Reports in Critical Care 2019; 2019: 1 doi: 10.1155/2019/2358562
|
| 73 |
Hydration effect on kidney function and serum electrolyte in children with tumor lysis syndrome (TLS) and risk of TLS. Journal of Basic and Clinical Physiology and Pharmacology 2021; 32(4): 603 doi: 10.1515/jbcpp-2020-0412
|
| 74 |
Mitchell H. Rosner, Mark A. Perazella. Acute kidney injury in the patient with cancer. Kidney Research and Clinical Practice 2019; 38(3): 295 doi: 10.23876/j.krcp.19.042
|
| 75 |
Adnan Humam Waseem Hajjar, Shahem Abbarh, Abdulrahman Al-Mashdali, Awni Alshurafa, Mohammad Abu-Tineh, Hana Qasim, Khalid Ahmed, Mohamed A Yassin. Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case Report. Cureus 2022; doi: 10.7759/cureus.24386
|
| 76 |
Jen DeSalvo, Allison L Rossetti. Infection Masquerading As Spontaneous Tumor Lysis Syndrome. Cureus 2023; doi: 10.7759/cureus.40503
|
| 77 |
Hoda Pourhassan, Waasil Kareem, Vaibhav Agrawal, Ibrahim Aldoss. Important Considerations in the Intensive Care Management of Acute Leukemias. Journal of Intensive Care Medicine 2024; 39(4): 291 doi: 10.1177/08850666231193955
|
| 78 |
Saurabh Vig, Seema Mishra, Kanika Rustagi, Swati Bhan. Opioid toxicity with underlying tumour lysis syndrome in a patient with CMML: a diagnostic and therapeutic challenge. BMJ Case Reports 2018; : bcr-2018-225646 doi: 10.1136/bcr-2018-225646
|
| 79 |
Tao Zhou, Jianfang Zhu, Dan Shang, Chuxing Chai, Youzhen Li, Haiying Sun, Yongqin Li, Meng Gao, Min Li. Mitochondria-anchoring and AIE-active photosensitizer for self-monitored cholangiocarcinoma therapy. Materials Chemistry Frontiers 2020; 4(11): 3201 doi: 10.1039/D0QM00503G
|
| 80 |
Eslam E. Abd El-Fattah. Tumor lysis syndrome promotes cancer chemoresistance and relapse through AMPK inhibition. International Immunopharmacology 2023; 114: 109568 doi: 10.1016/j.intimp.2022.109568
|
| 81 |
Lorenzo Gianni, Maria Vittoria Stefania Nicoletti, Valentina Arcangeli. Breast Cancer. 2017; : 697 doi: 10.1007/978-3-319-48848-6_58
|
| 82 |
Beenish Faheem, Sudarsan Kollimuttathuillam, Hamdallah Ashkar, Michael Maroules. Spontaneous Tumor Lysis Syndrome in T-Cell Leukemia. Cureus 2020; doi: 10.7759/cureus.11002
|
| 83 |
Tidapa Rattanaumpa, Santi Maensiri, Kamonwad Ngamchuea. Microporous carbon in the selective electro-oxidation of molecular biomarkers: uric acid, ascorbic acid, and dopamine. RSC Advances 2022; 12(29): 18709 doi: 10.1039/D2RA03126D
|
| 84 |
David F. Kisor. Pharmacogenomics: Foundations, Competencies, and the Pharmacists’ Patient Care Process, 2nd Edition. 2022; doi: 10.21019/9781582123844.ch21
|
| 85 |
Seiya Urae, Kayori Tsuruoka, Sayaka Kuroya, Yugo Shibagaki. Tumor Lysis-like Syndrome in Eosinophilic Disease of the Lung: A Case Report and Review of the Literature. Internal Medicine 2016; 55(20): 3029 doi: 10.2169/internalmedicine.55.6659
|
| 86 |
Nicole Gri, Yaroslava Longhitano, Christian Zanza, Valentina Monticone, Damiano Fuschi, Andrea Piccioni, Abdelouahab Bellou, Ciro Esposito, Iride Francesca Ceresa, Gabriele Savioli. Acute Oncologic Complications: Clinical–Therapeutic Management in Critical Care and Emergency Departments. Current Oncology 2023; 30(8): 7315 doi: 10.3390/curroncol30080531
|
| 87 |
Olivia Sherwen, Madeleine Kate Baron, Natalie Strachan Murray, Paul Anthony Heaton, Jane Gamble, Siba Prosad Paul. The recognition and nursing management of common oncological emergencies in children. British Journal of Nursing 2022; 31(1): 20 doi: 10.12968/bjon.2022.31.1.20
|
| 88 |
Suet Ying Lam, Eugene Yu-hin Chan, Frankie Wai Tso Cheng, Alison Lap Tak Ma, Shau Yin Ha. Acute kidney injury in children with haematological malignancy: a territory-wide study. Pediatric Nephrology 2023; 38(11): 3823 doi: 10.1007/s00467-023-06010-z
|
| 89 |
Dominic J. Fowler-Shorten, Charlotte Hellmich, Matthew Markham, Kristian M. Bowles, Stuart A. Rushworth. BCL-2 inhibition in haematological malignancies: Clinical application and complications. Blood Reviews 2024; 65: 101195 doi: 10.1016/j.blre.2024.101195
|
| 90 |
Rudolf A. de Boer, Joseph Pierre Aboumsallem, Valentina Bracun, Douglas Leedy, Richard Cheng, Sahishnu Patel, David Rayan, Svetlana Zaharova, Jennifer Rymer, Jennifer M. Kwan, Joshua Levenson, Claudio Ronco, Paaladinesh Thavendiranathan, Sherry-Ann Brown. A new classification of cardio-oncology syndromes. Cardio-Oncology 2021; 7(1) doi: 10.1186/s40959-021-00110-1
|